Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
SkinBioTherapeutics PLC
SBTXCurrent price
14.25 GBX
-0.5 GBX (-3.39%)
Last closed
14.75 GBX
Company
www.skinbiotherapeutics.com
ISIN
GB00BF33H870
Sector
Healthcare
Industry
Biotechnology
Exchange
London Exchange
Capitalization
38 010 121 GBX
Yield for 12 month
-41.84 %
1Y
3Y
5Y
10Y
15Y
SBTX
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has an agreement with Croda Plc; and operates two research programmes with the University of Manchester, an oral programme and an inflammation study. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom. Address: The Core, Newcastle upon Tyne, United Kingdom, NE4 5TF
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3 708.36 GBXP/E ratio
–Dividend Yield
–Current Year
+13 217 076 GBX
Last Year
+7 482 553 GBX
Current Quarter
+10 666 802 GBX
Last Quarter
+5 511 943 GBX
Current Year
+4 168 897 GBX
Last Year
+1 592 897 GBX
Current Quarter
+6 828 181 GBX
Last Quarter
+561 354 GBX
Key Figures SBTX
1 year
3 years
5 years
10 years
EBITDA
-3 001 690 GBX
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-61.18 %
PEG Ratio
–
Return On Equity TTM
-118.64 %
Wall Street Target Price
3 708.36 GBX
Revenue TTM
161 787 GBX
Book Value
0.019 GBX
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
38.4 %
Dividend Yield
–
Gross Profit TTM
45 376 GBX
Earnings per share
-0.02 GBX
Diluted Eps TTM
-0.02 GBX
Most Recent Quarter
IV 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics SBTX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SBTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation SBTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
217.9674
Price Sales TTM
234.9394
Enterprise Value EBITDA
-8.0802
Price Book MRQ
10.4018
Financials SBTX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SBTX
For 52 weeks
7.01 GBX
27 GBX
50 Day MA
12.68 GBX
Shares Short Prior Month
–
200 Day MA
10.82 GBX
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart